A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...

In a recent study published in the JAMA, a group of researchers evaluated whether a treatment strategy using oral glucose-lowering agents (metformin and glyburide) is non-inferior to insulin in ...

The yearlong trial found that the new drug was able to reduce HbA1c levels more than Ozempic.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like peptide-1 (GLP-1) medications. The U.S. Food and Drug Administration (FDA) has ...

The study found that the drug stimulates insulin secretion, suppresses appetite and increases satisfaction to promote weight ...

Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. Today, at the American Diabetes Association's Scientific Session, Mass ...

For many people with type 2 diabetes, the problem is not just finding a drug that works. It is finding one they can realistically live with. A once-daily pill called elecoglipron is now drawing ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...